Faculty Profiles - SHIBATA Masahiko

Papers - SHIBATA Masahiko

Division display >> ／ All the affair displays1 - 111 of about 111

山間部の中核病院,がん治療センター開設365日(解説)

柴田昌彦, 成田尚也, 大野史絵, 伊藤絵美, 矢澤貴, 長谷川翔, 井上典夫, 持田謙介, 前田佳一郎, 南嘉輝, 遠藤俊吾, 高田信, 鈴木義行, 河野浩二, 竹之下誠一

癌と化学療法 51 ( 2 ) 153 - 158 2024.2

はじめに

柴田昌彦, 河野浩二

消化器がん免疫療法の現在　がん治療の転換点に立つ 4 - 5 2023.9

2.がん患者の全身・がん局所で起きている変化

柴田昌彦

消化器がん免疫療法の現在　がん治療の転換点に立つ 9 - 16 2023.9

監修にあたって

柴田昌彦

Oncologic Emergency A to Z 2023.9

第1章総論

柴田昌彦

Oncologic Emergency A to Z 1 - 11 2023.9

Poetic City, Long Coat そして Warshawski

柴田昌彦

W’Waves 29 ( 1 ) 39 - 41 2023

Inhibiting VEGF in cancer immunotherapy.

Shibata M, Kono K, Takenoshita S

Clin Immunol Comm. 2 12 - 16 2022.12

Metabolic Impact of Immune-Suppressor Cells in Cancer Patients.

Shibata M, Inukai A, Yoshimori D, Ashizawa M, Nakajima T, Takada M, Yazawa T, Mimura K, Inoue N, Watanabe T, Tachibana K, Muto S, Kono K, Endo S, Takenoshita S

Journal of Surgical Research 5 ( 1 ) 134 - 144 2022.12

Myeloid-derived suppressor cells: Cancer, autoimmune diseases, and more.

Shibata M, Nanno K, Yoshimori D, Nakajima T, Takada M, Yazawa T, Mimura K, Inoue N, Watanabe T, Tachibana K, Muto S, Momma T, Suzuki Y, Kono K, Endo S, Takenoshita S

Oncotarget 13 1273 - 1285 2022.11

基礎編2章がん微小環境　2.MDSC(骨髄由来抑制細胞)

柴田昌彦

がん免疫ペディア　腫瘍免疫学・がん免疫療法の全てをまるごと理解！ 134 - 135 2022.3

Associations between anger and chronic primary pain: a systematic review and meta-analysis

Adachi T, Yamada K, Fujino H, Enomoto K, Shibata M.

Scand J Pain. 22 ( 1 ) 1 - 13 2021.12

IL-17A in Ovarian Cancer.

Watanabe T, Shibata M, Soeda S, Furukawa S, Fujimori K, Kono K, Takenoshita S.

Journal of Cancer Therapy. 11 ( 10 ) 605 - 616 2020.10

がん免疫療法の副作用〔総論〕

柴田昌彦

よくわかるがん免疫療法ガイドブック－患者さんとご家族のために－ 28 - 31 2020

癌と炎症を学ぶ連載「癌と炎症を学」を終了するにあたり

柴田昌彦

消化器外科 43 ( 12 ) 1709 - 1710 2020

癌免疫カンファレンスルーム(最終回)　連載を終えるにあたって

河野浩二, 柴田昌彦

消化器外科 42 ( 11 ) 1610 - 1611 2019.10（ ISSN:0387-2645 ）

IL-17A in oncology.

Shibata M, Mimura K, Shimura T, Kono K, Ohto H, Takenoshita S.

Annals of Cancer Research and Therapy 27 ( 2 ) 59 - 63 2019.7（ ISSN:1344-6835 ）

【癌と炎症を学ぶ第１回】“癌と炎症” 概説；連載の序にかえて

柴田昌彦

消化器外科 42 ( 12 ) 1723 - 1729 2019

Prognostic impact of interleukin-6 and C-reactive protein on patients with breast cancer.

Shimura T, Shibata M, Gonda K, Murakami Y, Noda M, Tachibana K, Abe N, Ohtake T.

Oncology letters 17 ( 6 ) 5139 - 5146 2019

Prognostic impact of soluble intercellular adhesion molecule-1 in hepatocellular carcinoma.

Shimura T, Shibata M, Gonda K, Kofunato Y, Ishigame T, Okada R, Sato N, Kimura T, Kenjo A, Marubashi S.

Oncol Lett 16 ( 5 ) 6013 - 6018 2018.11

Prognostic impact of elevated preoperative C-reactive protein on patients with differentiated thyroid carcinoma.

Shimura T, Shibata M, Gonda K, Matsumoto Y, Nakano K, Iwadate M, Suzuki S, Suzuki S

J Surg Res 231 338 - 345 2018.11

大腸癌再発症例にAfliberceptを投与しPRを得た症例

権田憲士, 藤田正太郎, 柴田昌彦, 畠山優一, 立谷陽介, 六角裕一, 佐瀬善一郎, 門馬智之, 大木進司, 佐治重衡, 河野浩二

癌と化学療法 45 ( 10 ) 1539 - 1542 2018.10（ ISSN:0385-0684 ）

傍腫瘍性小脳変性症に直腸癌を合併した1例

権田憲士, 菊池智弘, 柴田昌彦, 畠山優一, 立谷陽介, 六角裕一, 遠藤久仁, 藤田正太郎, 坂本渉, 早瀬傑, 岡山洋和, 花山寛之, 多田武志, 楡井東, 氏家大輔, 山田玲央, 佐瀬善一郎, 門馬智之, 大木進司, 河野浩二

癌と化学療法 45 ( 10 ) 1510 - 1512 2018.10（ ISSN:0385-0684 ）

Prognostic impact of preoperative lymphocyte-to-monocyte ratio in patients with colorectal cancer with special reference to myeloid-derived suppressor cells.

Shimura T, Shibata M, Gonda K, Hayase S, Sakamoto W, Okayama H, Fujita S, Saito M, Momma T, Ohki S, Kono K

Fukushima journal of medical science 64 ( 2 ) 64 - 72 2018.8（ ISSN:0016-2590 ）

Immunotherapy for esophageal squamous cell carcinoma: a review.

Mimura K, Yamada L, Ujiie D, Hayase S, Tada T, Hanayama H, Thar Min AK, Shibata M, Momma T, Saze Z, Ohki S, Kono K

Fukushima journal of medical science 64 ( 2 ) 46 - 53 2018.8（ ISSN:0016-2590 ）

Serum transthyretin level is associated with prognosis of patients with gastric cancer.

Shimura T, Shibata M, Gonda K, Okayama H, Saito M, Momma T, Ohki S, Kono K

Journal of Surgical Research 227 145 - 150 2018.7（ ISSN:00224804 ）

Clinical significance of serum transthyretin level in patients with hepatocellular carcinoma.

Shimura T, Shibata M, Kofunato Y, Okada R, Ishigame T, Kimura T, Kenjo A, Marubashi S

ANZ journal of surgery 2018.3（ ISSN:1445-1433 ）

Augmentation of antibody-dependent cellular cytotoxicity with defucosylated monoclonal antibodies in patients with GI-tract cancer.

Nakajima T, Okayama H, Ashizawa M, Noda M, Aoto K, Saito M, Monma T, Ohki S, Shibata M, Takenoshita S, Kono K

Oncology letters 15 ( 2 ) 2604 - 2610 2018.2（ ISSN:1792-1074 ）

【腫瘍制御にかかわる各種細胞群】骨髄由来免疫抑制細胞(MDSC)と腫瘍制御

柴田昌彦, 権田憲士, 三村耕作, 河野浩二, 大戸斉, 竹之下誠一

炎症と免疫 26 ( 2 ) 115 - 121 2018.2（ ISSN:0918-8371 ）

Current status of cancer immunotherapy for esophageal squamous cell carcinoma

Kono K., Mimura K., Yamada R., Ujiie D., Hayase S., Tada T., Hanayama H., Min A., Shibata M., Momma T., Saze Z., Ohki S.

Esophagus 15 ( 1 ) 2018.1（ ISSN:16129059 ）

Current status of cancer immunotherapy for esophageal squamous cell carcinoma.

Kono K, Mimura K, Yamada L, Ujiie D, Hayase S, Tada T, Hanayama H, Min AKT, Shibata M, Momma T, Saze Z, Ohki S

Esophagus 15 ( 1 ) 1 - 9 2018.1（ ISSN:1612-9059 ）

SIRS, CARS and MARS in relationship to cancer cachexia and its clinical implications.

Shibata M, Gonda K, Shimura T, Sakurai K, Takenoshita S

Annals of Cancer Research and Therapy 26 ( 1 ) 54 - 59 2018.1（ ISSN:1344-6835 ）

A case of clinical complete response of colorectal liver metastasis following chemotherapy with S-1 and oxaliplatin (SOX) in combination with bevacizumab

Azuhata T, Shibata S, Nakamura K, Kawano D, Terakado Y, Azuhata I, Sakurai A, Yamada T, Sugita K, Tomita R, Tsuyama Y, Tanjoh K, Azuhata S

Annals of Cancer Research and Therapy 26 ( 2 ) 101 - 104 2018

Clinical significance of serum transthyretin level in patients with hepatocellular carcinoma.

Shimura T, Shibata M, Kofunato Y, Okada R, Ishigame T, Kimura T, Kenjo A, Marubashi S.

ANZ J Surg 88 ( 12 ) 1328 - 1332 2018

IL-17 and VEGF are increased and correlated to systemic inflammation, immune suppression, and malnutrition in patients with breast cancer

Tachibana K., Shibata M., Gonda K., Matsumoto Y., Nakajima T., Abe N., Ohtake T., Ohto H., Kono K., Takenoshita S.

European Journal of Inflammation 15 ( 3 ) 219 - 228 2017.12（ ISSN:1721727X ）

Elevated neutrophil-to-lymphocyte ratio is associated with nutritional impairment, immune suppression, resistance to S-1 plus cisplatin, and poor prognosis in patients with stage IV gastric cancer.

Gonda K, Shibata M, Sato Y, Washio M, Takeshita H, Shigeta H, Ogura M, Oka S, Sakuramoto S

Molecular and clinical oncology 7 ( 6 ) 1073 - 1078 2017.12（ ISSN:2049-9450 ）

長期生存を認めた原発不明癌の3症例

権田憲士, 柴田昌彦, 安田政実, 立谷陽介, 畠山優一, 河野浩二, 六角裕一

癌と化学療法 44 ( 10 ) 950 - 952 2017.10（ ISSN:0385-0684 ）

癌免疫カンファレンスルーム(第2回)　癌患者で起きている生体の変化

柴田昌彦

消化器外科 40 ( 11 ) 1575 - 1580 2017.10（ ISSN:0387-2645 ）

化学療法によりpCRが得られた直腸癌の2症例

権田憲士, 立谷陽介, 畠山優一, 柴田昌彦, 河野浩二, 六角裕一

癌と化学療法 44 ( 10 ) 944 - 946 2017.10（ ISSN:0385-0684 ）

Clinical Significance of Soluble Intercellular Adhesion Molecule-1 and Interleukin-6 in Patients with Extrahepatic Cholangiocarcinoma.

Shimura T, Shibata M, Gonda K, Kofunato Y, Okada R, Ishigame T, Kimura T, Kenjo A, Marubashi S, Kono K, Takenoshita S

Journal of investigative surgery : the official journal of the Academy of Surgical Research 1 - 8 2017.9（ ISSN:0894-1939 ）

Significance of Circulating Galectin-3 in Patients with Pancreatobiliary Cancer.

Shimura T, Shibata M, Gonda K, Kofunato Y, Okada R, Ishigame T, Kimura T, Kenjo A, Kono K, Marubashi S

Anticancer research 37 ( 9 ) 4979 - 4986 2017.9（ ISSN:0250-7005 ）

Myeloid-derived suppressor cells are increased and correlated with type 2 immune responses, malnutrition, inflammation, and poor prognosis in patients with breast cancer.

Gonda K, Shibata M, Ohtake T, Matsumoto Y, Tachibana K, Abe N, Ohto H, Sakurai K, Takenoshita S

Oncology letters 14 ( 2 ) 1766 - 1774 2017.8（ ISSN:1792-1074 ）

IL-17 and VEGF are significantly associated with disease progression involving systemic inflammation in patients with gastric and colorectal cancers(和訳中)

Minamikawa Kazuo, Shibata Masahiko, Gonda Kenji, Ujiie Daisuke, Ashizawa Mai, Nakajima Takahiro, Okayama Hirokazu, Sakamoto Wataru, Saito Motonobu, Momma Tomoyuki, Mimura Kousaku, Ohki Shinji, Shimura Tatsuo, Ohto Hitoshi, Takenoshita Seiichi, Kono Koji

Annals of Cancer Research and Therapy 25 ( 2 ) 67 - 76 2017.8（ ISSN:1344-6835 ）

Increased neutrophil-to-lymphocyte ratio is a novel marker for nutrition, inflammation and chemotherapy outcome in patients with locally advanced and metastatic esophageal squamous cell carcinoma.

Sato Y, Gonda K, Harada M, Tanisaka Y, Arai S, Mashimo Y, Iwano H, Sato H, Ryozawa S, Takahashi T, Sakuramoto S, Shibata M

Biomedical reports 7 ( 1 ) 79 - 84 2017.7（ ISSN:2049-9434 ）

IL-17 and VEGF are significantly associated with disease progression involving systemic inflammation in patients with gastric and colorectal cancers

Minamikawa K., Shibata M., Gonda K., Ujiie D., Ashizawa M., Nakajima T., Okayama H., Sakamoto W., Saito M., Momma T., Mimura K., Ohki S., Shimura T., Ohto H., Takenoshita S., Kono K.

Annals of Cancer Research and Therapy 25 ( 2 ) 67 - 76 2017.1（ ISSN:13446835 ）

Significance of Circulating Galectin-3 in Patients with Hepato-biliary and Pancreatic Cancer

SHIMURA Tatsuo, SHIBATA Masahiko, KOFUNATO Yasuhide, ISHIGAME Teruhide, OKADA Ryo, KIMURA Takashi, KENJO Akira, MARUBASHI Shigeru, OHKI Shinji, KONO Koji, TAKENOSHITA Seiichi

Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) 78 ( 4 ) 633 - 637 2017（ ISSN:1345-2843 ）

Chapter 14, Systemic Inflammation causing multiple clinical symptoms in gastrointestinal cancer.

Shibata M, Gonda K, Takenoshita S.

In Gastrointestinal Cancers vol.2 (Kumar AK and Prasad S ed) Nova Science Publishers, New York 311 - 323 2017

癌免疫カンファレンスルーム、連載の開始にあたって

柴田昌彦, 河野浩二

消化器外科 40 ( 10 ) 1474 - 1476 2017

Association between circulating galectin-3 levels and the immunological, inflammatory and nutritional parameters in patients with colorectal cancer.

Shimura T, Shibata M, Gonda K, Nakajima T, Chida S, Noda M, Suzuki S, Nakamura I, Ohki S, Takenoshita S

Biomedical reports 5 ( 2 ) 203 - 207 2016.8（ ISSN:2049-9434 ）

血中ガレクチン-3は甲状腺癌患者における血管新生因子、栄養状態指標、全身性炎症と相関する(Circulating galectin-3 correlates with angiogenetic factors, indicators of nutritional condition and systemic inflammation in patients with thyroid cancer)

Shimura Tatsuo, Shibata Masahiko, Gonda Kenji, Nakajima Takahiro, Chida Shun, Noda Masaru, Suzuki Satoshi, Nakamura Izumi, Nakano Keiichi, Fukushima Toshihiko, Suzuki Shinichi, Takenoshita Seiichi

Annals of Cancer Research and Therapy 24 ( 1 ) 35 - 40 2016.5（ ISSN:1344-6835 ）

ステージIV食道癌患者における血中ガレクチン-3は血管新生因子および全身性炎症指標と相関する(Circulating galectin-3 correlates with angiogenetic factors and indicators of systemic inflammation in patients with stage IV esophageal cancer)

Shimura Tatsuo, Shibata Masahiko, Gonda Kenji, Nakajima Takahiro, Chida Shun, Noda Masaru, Suzuki Satoshi, Nakamura Izumi, Ohki Shinji, Takenoshita Seiichi

Annals of Cancer Research and Therapy 24 ( 1 ) 30 - 34 2016.5（ ISSN:1344-6835 ）

血清ガレクチン-3値上昇は大腸癌患者の予後不良と関連している(Elevated serum galectin-3 is associated with poor prognosis in patients with colorectal carcinoma)

Shimura Tatsuo, Shibata Masahiko, Gonda Kenji, Nakajima Takahiro, Chida Shun, Noda Masaru, Suzuki Satoshi, Nakamura Izumi, Ohki Shinji, Takenoshita Seiichi

Annals of Cancer Research and Therapy 24 ( 1 ) 12 - 16 2016.5（ ISSN:1344-6835 ）

Circulating galectin-3 correlates with angiogenetic factors and indicators of systemic inflammation in patients with stage IV esophageal cancer

Shimura T., Shibata M., Gonda K., Nakajima T., Chida S., Noda M., Suzuki S., Nakamura I., Ohki S., Takenoshita S.

Annals of Cancer Research and Therapy 24 ( 1 ) 30 - 34 2016.3（ ISSN:13446835 ）

Circulating galectin-3 correlates with angiogenetic factors, indicators of nutritional condition and systemic inflammation in patients with thyroid cancer

Shimura T., Shibata M., Gonda K., Nakajima T., Chida S., Noda M., Suzuki S., Nakamura I., Nakano K., Fukushima T., Suzuki S., Takenoshita S.

Annals of Cancer Research and Therapy 24 ( 1 ) 35 - 40 2016.3（ ISSN:13446835 ）

MDSC: Myeloid-derived suppressor cells

Shibata M., Gonda K., Takenoshita S.

Immunotherapy of Cancer: An Innovative Treatment Comes of Age 323 - 334 2016.2

Elevated serum galectin-3 is associated with poor prognosis in patients with colorectal carcinoma

Shimura T., Shibata M., Gonda K., Nakajima T., Chida S., Noda M., Suzuki S., Nakamura I., Ohki S., Takenoshita S.

Annals of Cancer Research and Therapy 24 ( 1 ) 12 - 16 2016.1（ ISSN:13446835 ）

Systemic inflammation causing multiple clinical symptoms in gastrointestinal cancer

Shibata M., Gonda K., Takenoshita S.

Gastrointestinal Cancers: Prevention, Detection and Treatment 2 311 - 324 2016.1

The Effect of Guidance regarding Home Exercise and ADL on Adolescent Females Suffering from Adverse Effects after HPV Vaccination in Japanese Multidisciplinary Pain Centers.

Ushida T, Shibata M, Kitahara M, Yabuki S, Sumitani M, Murakami T, Iseki M, Hosoi M, Shiokawa H, Tetsunaga T, Nishie H, Fukui S, Kawasaki M, Inoue S, Nishihara M, Aono S, Ikemoto T, Kawai T, Arai YC

Pain research & management 2016 3689352 2016（ ISSN:1203-6765 ）

進行がんにおける免疫抑制システムとその制御について

柴田昌彦

日本外科系連合学会誌 40 ( 4 ) 840 - 842 2015.8（ ISSN:0385-7883 ）

Our contrivances to diminish complications after pylorus-preserving pancreaticoduodenectomy.

Shimura T, Suzuki H, Araki K, Kobayashi T, Yashima R, Kohunato Y, Okada R, Shibata M, Kuwano H, Takenoshita S

International surgery 100 ( 5 ) 882 - 90 2015.5（ ISSN:0020-8868 ）

【免疫力が変えるがんの治療・再発予防効果　次世代がん治療として世界中が注目する免疫療法について、専門家16人が語る最新ガイド】　がんと免疫　基本と最新情報免疫抑制の最新研究動向

柴田昌彦

ライフライン21がんの先進医療別冊 18 - 21 2015.2

Cachexia, immunological participation

Shibata M., Gonda K.

International Journal of Cancer Research and Prevention 8 ( 3 ) 367 - 376 2015.1（ ISSN:15541134 ）

OP-062-5 乳癌患者における細胞性免疫能の抑制状態と化学療法による改善効果(OP-062 乳腺基礎,一般演題,第114回日本外科学会定期学術集会)

権田憲士, 柴田昌彦, 大竹徹, 渡辺久美子, 吉田清香, 松本佳子, 中島隆弘, 志村龍男, 櫻井健一, 隈元謙介, 鈴木眞一, 竹之下誠一

日本外科学会雑誌 115 ( 2 ) 2014.3（ ISSN:18801129 ）

PS-178-8 癌患者の血中VEGF濃度とMDSCが関与する免疫抑制メカニズムの検討(PS-178 基礎腫瘍免疫,ポスターセッション,第114回日本外科学会定期学術集会)

柴田昌彦, 権田憲士, 中島隆宏, 松本佳子, 管家康之, 鈴志野聖子, 中村泉, 隈元謙介, 志村龍男, 竹之下誠一

日本外科学会雑誌 115 ( 2 ) 2014.3（ ISSN:18801129 ）

PS-137-3 胃癌における幽門側胃切除術後におけるQOLと空腹期強収縮帯との関連について(PS-137 胃その他-3,ポスターセッション,第114回日本外科学会定期学術集会)

富田涼一, 櫻井健一, 藤崎滋, 朴英智, 柴田昌彦

日本外科学会雑誌 115 ( 2 ) 2014.3（ ISSN:18801129 ）

Serum levels of rapid turnover proteins are decreased and related to systemic inflammation in patients with ovarian cancer.

Watanabe T, Shibata M, Nishiyama H, Soeda S, Furukawa S, Gonda K, Takenoshita S, Fujimori K

Oncology letters 7 ( 2 ) 373 - 377 2014.2（ ISSN:1792-1074 ）

[Immunological cell therapy].

Shibata M., Gonda K., Kumamoto K., Takenoshita S.

Nihon rinsho. Japanese journal of clinical medicine 72 ( 1 ) 42 - 48 2014.1（ ISSN:00471852 ）

[Immunological cell therapy].

Shibata M, Gonda K, Kumamoto K, Takenoshita S

Nihon rinsho. Japanese journal of clinical medicine 72 ( 1 ) 42 - 8 2014.1（ ISSN:0047-1852 ）

【大腸癌の最新治療-治癒に向けた最先端研究-】基礎研究　免疫細胞療法

柴田昌彦, 権田憲士, 隈元謙介, 竹之下誠一

日本臨床 72 ( 1 ) 42 - 48 2014.1（ ISSN:0047-1852 ）

潰瘍性大腸炎に対するJ型結腸嚢肛門吻合後の小児患者における仙骨運動神経末端潜時(Sacral Nerve Terminal Motor Latency in Child Patients after Ileal J-Pouch-Anal Anastomosis for Ulcerative Colitis)

Tomita Ryouichi, Sugito Kiminobu, Inoue Mikiya, Ikeda Taro, Sakurai Kenichi, Fujisaki Shigeru, Park Eichi, Koshinaga Tsugumichi, Shibata Masahiko

日本臨床生理学会雑誌 43 ( 4・6 ) 147 - 150 2013.12（ ISSN:0286-7052 ）

Immunosuppression involving increased myeloid-derived suppressor cell levels, systemic inflammation and hypoalbuminemia are present in patients with anaplastic thyroid cancer.

Suzuki S, Shibata M, Gonda K, Kanke Y, Ashizawa M, Ujiie D, Suzushino S, Nakano K, Fukushima T, Sakurai K, Tomita R, Kumamoto K, Takenoshita S

Molecular and clinical oncology 1 ( 6 ) 959 - 964 2013.11（ ISSN:2049-9450 ）

大腸癌局所再発による悪性小腸イレウスの検討

富田凉一, 藤崎滋, 櫻井健一, 杉藤公信, 越永従道, 柴田昌彦

癌と化学療法 40 ( 12 ) 1942 - 1943 2013.11（ ISSN:0385-0684 ）

Serum levels of vascular endothelial growth factor are increased and correlate with malnutrition, immunosuppression involving MDSCs and systemic inflammation in patients with cancer of the digestive system

Nakamura I., Shibata M., Gonda K., Yazawa T., Shimura T., Anazawa T., Suzuki S., Sakurai K., Koyama Y., Ohto H., Tomita R., Gotoh M., Takenoshita S.

Oncology Letters 5 ( 5 ) 1682 - 1686 2013.10（ ISSN:17921074 ）

【免疫療法と免疫抑制細胞】急速に進歩する「新時代のがん免疫治療」　免疫抑制からの脱却による「がん治療の展望」

柴田昌彦

ライフライン21がんの先進医療 10 40 - 43 2013.7

PS-202-5 消化器癌患者の栄養障害とその免疫メカニズムの検討(PS ポスターセッション,第113回日本外科学会定期学術集会)

柴田昌彦, 矢澤貴, 権田憲士, 穴沢貴行, 木村隆, 見城明, 鈴木聡, 中村泉, 大木進司, 土屋貴男, 志村龍男, 後藤満一, 竹之下誠一